2022 Q1 Form 10-Q Financial Statement

#000121390022023961 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $500.0K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit $500.0K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $331.0K $161.0K
YoY Change 105.59%
% of Gross Profit 32.2%
Research & Development $6.000K
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $1.000K
YoY Change -100.0% -66.67%
% of Gross Profit 0.2%
Operating Expenses $337.0K $0.00
YoY Change
Operating Profit -$337.0K $500.0K
YoY Change -167.4%
Interest Expense -$32.00K -$220.0K
YoY Change -85.45%
% of Operating Profit -44.0%
Other Income/Expense, Net
YoY Change
Pretax Income -$369.0K $251.0K
YoY Change -247.01%
Income Tax
% Of Pretax Income
Net Earnings -$369.0K $251.0K
YoY Change -247.01%
Net Earnings / Revenue 50.2%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$6.829K $6.195K
COMMON SHARES
Basic Shares Outstanding 54.03M shares
Diluted Shares Outstanding 54.03M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.415M $452.0K
YoY Change 655.53% -27.68%
Cash & Equivalents $3.415M $452.0K
Short-Term Investments
Other Short-Term Assets $28.00K $55.00K
YoY Change -49.09% 7.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.443M $507.0K
YoY Change 579.09% -25.0%
LONG-TERM ASSETS
Property, Plant & Equipment $21.00K $11.00K
YoY Change 90.91% -21.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.00K $11.00K
YoY Change 90.91% -21.43%
TOTAL ASSETS
Total Short-Term Assets $3.443M $507.0K
Total Long-Term Assets $21.00K $11.00K
Total Assets $3.464M $518.0K
YoY Change 568.73% -24.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.00K $238.0K
YoY Change -68.07% -6.3%
Accrued Expenses $177.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $832.0K
YoY Change -3.14%
Total Short-Term Liabilities $253.0K $1.204M
YoY Change -78.99% -3.76%
LONG-TERM LIABILITIES
Long-Term Debt $299.0K $482.0K
YoY Change -37.97% -21.75%
Other Long-Term Liabilities $47.00K
YoY Change -63.57%
Total Long-Term Liabilities $299.0K $529.0K
YoY Change -43.48% -28.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $253.0K $1.204M
Total Long-Term Liabilities $299.0K $529.0K
Total Liabilities $552.0K $1.733M
YoY Change -68.15% -13.18%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.912M -$1.215M
YoY Change
Total Liabilities & Shareholders Equity $3.464M $518.0K
YoY Change 568.73% -24.93%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$369.0K $251.0K
YoY Change -247.01%
Depreciation, Depletion And Amortization $0.00 $1.000K
YoY Change -100.0% -66.67%
Cash From Operating Activities -$133.0K $353.0K
YoY Change -137.68% -199.44%
INVESTING ACTIVITIES
Capital Expenditures -$12.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$12.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.000K
YoY Change -100.63%
NET CHANGE
Cash From Operating Activities -133.0K 353.0K
Cash From Investing Activities -12.00K
Cash From Financing Activities -6.000K
Net Change In Cash $0.00 $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$133.0K $353.0K
Capital Expenditures -$12.00K
Free Cash Flow -$121.0K $353.0K
YoY Change -134.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Stock Issued1
StockIssued1
USD
CY2022Q1 usdr Issuance Of Shares In Exchange For Convertible Loans
IssuanceOfSharesInExchangeForConvertibleLoans
USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001638911
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2022Q1 usdr Expenses With Respect To Changes In Fair Value Of Option Granted In Equity Financing
ExpensesWithRespectToChangesInFairValueOfOptionGrantedInEquityFinancing
USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2022Q1 usdr Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020Q4 usdr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
shares

Files In Submission

Name View Source Status
0001213900-22-023961-index-headers.html Edgar Link pending
0001213900-22-023961-index.html Edgar Link pending
0001213900-22-023961.txt Edgar Link pending
0001213900-22-023961-xbrl.zip Edgar Link pending
f10q0322ex31-1_uasdrone.htm Edgar Link pending
f10q0322ex31-2_uasdrone.htm Edgar Link pending
f10q0322ex32-1_uasdrone.htm Edgar Link pending
f10q0322ex32-2_uasdrone.htm Edgar Link pending
f10q0322_uasdrone.htm Edgar Link pending
f10q0322_uasdrone_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usdr-20220331.xsd Edgar Link pending
usdr-20220331_cal.xml Edgar Link unprocessable
usdr-20220331_def.xml Edgar Link unprocessable
usdr-20220331_lab.xml Edgar Link unprocessable
usdr-20220331_pre.xml Edgar Link unprocessable